Literature DB >> 26153996

Biotechs recoil at hedge fund manager's patent attacks.

Melanie Senior.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26153996     DOI: 10.1038/nbt0715-680b

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Patent challenges to antibody and gene-therapy firms on the rise.

Authors:  Charlotte Harrison
Journal:  Nat Biotechnol       Date:  2018-05-09       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.